Veracyte, Inc. - Common Stock (VCYT)
45.48
-0.66 (-1.43%)
Veracyte Inc. is a leading biotechnology company focused on advancing genomic medicine to improve patient care in oncology and other diseases
The company specializes in developing innovative diagnostic solutions that enhance the accuracy of clinical decision-making, particularly in the evaluation of thyroid nodules, lung cancer, and other conditions where traditional tissue biopsy can be inconclusive or invasive. By leveraging advanced genomic technology and a platform of proprietary tests, Veracyte aims to provide physicians and patients with reliable information that can inform treatment choices and ultimately lead to better outcomes in personalized medicine.
Frequently Asked Questions
Is Veracyte, Inc. - Common Stock publicly traded?
Yes, Veracyte, Inc. - Common Stock is publicly traded.
What exchange does Veracyte, Inc. - Common Stock trade on?
Veracyte, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Veracyte, Inc. - Common Stock?
The ticker symbol for Veracyte, Inc. - Common Stock is VCYT on the Nasdaq Stock Market
What is the current price of Veracyte, Inc. - Common Stock?
The current price of Veracyte, Inc. - Common Stock is 45.48
When was Veracyte, Inc. - Common Stock last traded?
The last trade of Veracyte, Inc. - Common Stock was at 4:00 pm EST on January 31st, 2025
What is the market capitalization of Veracyte, Inc. - Common Stock?
The market capitalization of Veracyte, Inc. - Common Stock is 3.07B
How many shares of Veracyte, Inc. - Common Stock are outstanding?
Veracyte, Inc. - Common Stock has 67.47M shares outstanding.